Moderna surprises the Street by predicting a bigger-than …

Moderna Cuts 2025 Sales Forecast By $1 Billion On Weak Vaccine …

2 weeks from now

2 days ago  · (Reuters) -Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 …

yahoo.com

Moderna Stock Forfeits Gains As First US Bird Flu Death Puts Vaccine ...

2 weeks from now

Jan 8, 2025  · After Moderna’s development of a COVID-19 vaccine fueled a massive surge in revenue — rising more than 2,000% in 2021 from the prior year, with the vaccine maker …

yahoo.com

Moderna Stock Surges After Covid Vaccine Sales Obliterate …

2 weeks from now

Aug 3, 2022  · Moderna also reiterated its view for $21 billion in full-year sales of its Covid vaccine. Analysts called for $22.2 billion in total revenue. Further, the company announced a new …

investors.com

Moderna's Stock Pops After Biotech Ekes Out A Surprise Profit, And ...

2 weeks from now

Nov 7, 2024  · Net product sales rose 4% to $1.8 billion in the quarter, driven by demand for the updated COVID-19 vaccine. Sales of Spikevax came to $1.8 billion, while FactSet was …

morningstar.com

Moderna's Stock Surges After Better-than-expected Quarterly Results

2 weeks from now

May 2, 2024  · The COVID vaccine maker reported a first-quarter net loss of $1.175 billion, or $3.07 a share, after net income of $79 million, or 19 cents a share, in the year-earlier period. …

morningstar.com

Moderna Stock Surges 14% After Covid Vaccine-Maker Surprises …

2 weeks from now

Feb 22, 2024  · During the fourth quarter, sales declined 45% year over year, "primarily due to a reduction in sales of the company's Covid-19 vaccine," Moderna said in its news release. …

investors.com

Moderna's Stock Pops After Surprise Quarterly Profit, Even As …

2 weeks from now

Feb 22, 2024  · Moderna Inc. shares (MRNA) jumped more than 7% premarket on Thursday after the company reported a surprise fourth-quarter profit, even as its COVID product sales …

morningstar.com

Moderna Reports Surprise Profit On Higher-than-expected COVID …

2 weeks from now

Nov 7, 2024  · Moderna still expects to make less from COVID vaccine sales this year than it did in 2023, however, and reaffirmed its 2024 sales forecast of $3 billion to $3.5 billion. The …

reuters.com

Moderna Crashes 21%. 'No Inflection In Sight' After Guidance

2 weeks from now

2 days ago  · Moderna estimates it ended 2024 with somewhere between $3 billion and $3.1 billion in product sales as it shifted its business toward treating COVID-19 as an "endemic" …

yahoo.com

Why Moderna Stock Just Crashed 21% - Nasdaq

2 weeks from now

2 days ago  · Moderna's (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot.. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET …

nasdaq.com

S&P 500 Gains And Losses Today: Moderna Plunges After Big Cut …

2 weeks from now

2 days ago  · Constellation Energy shares sank 8.5%, reversing some of Friday's surge of more than 25% posted by the stock after the energy producer announced an agreement to acquire …

investopedia.com

Moderna Stock Plunges Nearly 17% After Company Lowers 2025 …

2 weeks from now

Moderna now expects 2025 revenue of between $1.5 billion and $2.5 billion, most of which will come in the second half of the year. The majority of those sales will come from Moderna's …

msn.com

Moderna Stock Crashes 21% After Covid Vaccine Maker Slashes …

2 weeks from now

2 days ago  · Moderna stock crashed Monday after the Covid vaccine maker slashed its outlook for 2024 and 2025 sales and announced an expanded cost-cutting initiative.. ↑ X

investors.com

Moderna Price Levels To Watch After Stock's 12% Surge On Tuesday

2 weeks from now

Jan 8, 2025  · Moderna shares soared as investors placed bets that the pharmaceutical giant’s development of an H5N1 bird flu vaccine could boost sales after the first death linked to the …

investopedia.com

Moderna’s Recent Drop: 4 Reasons Bulls See Opportunity

2 weeks from now

Sep 16, 2024  · MRNA stock peaked at $497.40 on Aug. 9, 2021, as its COVID-19 vaccines generated over $36 billion in revenue. However, COVID-19 vaccine sales have fallen by more …

nasdaq.com

Moderna (MRNA) Stock Declines 87% In Three Years: 3 Key Points

2 weeks from now

Nov 28, 2024  · On November 30th, exactly 3 years ago, Moderna’s (MRNA) stock was priced at $352.43, but after losing 87.69% of its value, MRNA stock is priced at $43.50. This downturn …

nasdaq.com

Moderna Stock Surges After Covid Shot Obliterates Sales Views

2 weeks from now

May 4, 2022  · Despite a nearly $2 billion sales beat, Moderna restated its prediction for $21 billion in full-year advance purchase agreements for its two-shot Covid vaccine. The projection was …

investors.com

Moderna Stock Has Lost 94% Of Its Value Over Four Years. Is It A …

2 weeks from now

1 day ago  · Moderna stock peaked at 497.49 in August 2021, at the height of the Covid pandemic. Since then, the stock has fallen precipitously, down 94% over the past four years. Is Moderna …

investors.com